Deep Dive
Introduction to Reborn Longevity
Faye Mayson, the consulting CEO of Reborn Longevity, introduces London's first private longevity hospital. The clinic integrates precision preventive medicine with luxury hospitality, housed in a Georgian townhouse. Mayson criticizes the traditional medical system for being fragmented and impersonal. She emphasizes the importance of a holistic approach, where multiple doctors collaborate to diagnose and treat patients comprehensively. This method contrasts with large hospitals where such collaboration is rare due to logistical challenges.
The Reborn Method
Reborn Longevity has developed a unique method over 18 months, involving input from scientists and clinicians. The method ensures consistent care, regardless of which doctor a patient sees. Mayson highlights the systematic approach, rooted in P4 medicine principles: preventive, predictive, personalized, and participatory. The clinic focuses on cellular biology, examining genomes and proteomics to tailor treatments. This approach combines conventional medicine with functional practices, aiming for comprehensive patient care.
Therapeutic Plasma Exchange
Reborn Longevity offers therapeutic plasma exchange, a procedure traditionally used in the NHS since the 1950s. Mayson explains its application in reducing inflammation and treating cognitive decline in Alzheimer's patients. Recent studies, such as the AMBAR study, support its efficacy. The procedure involves removing inflammatory factors from the body, offering a recovery period. While costly, at £5,000 per session, Mayson argues it's a worthwhile investment for health improvement.
Expansion and Partnerships
Reborn Longevity is not planning to open new clinics but is exploring partnerships to expand its reach. Mayson mentions collaborations with other hospitals to share their methodology and train staff. A notable partnership is with the Dorchester Hotel Group, launching a sleep program in October. This initiative allows guests to receive clinical therapy while enjoying a luxurious stay. Mayson is also open to partnerships in China, recognizing the country's advanced biotech and AI sectors.